Pharma Mar, S.A. - Laporan Laba Rugi (TTM)

Pharma Mar, S.A.
AT ˙ WBAG ˙ ES0169501022
€ 81.30 ↓ -0.05 (-0.06%)
2025-07-10
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Pharma Mar, S.A. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 246 270 222 200 188 230 232 233 235 196 177 175 168 158 162 159 167 175 176 189
Change (%) 9.96 -17.85 -10.02 -5.72 22.16 0.84 0.35 1.06 -16.46 -9.78 -1.15 -3.79 -6.12 2.52 -2.06 5.16 4.70 0.51 7.69
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 11 14 18 17 14 16 14 16 17 14 12 10 11 10 9 10 9 8 10 10
Change (%) 30.35 28.24 -0.61 -22.03 20.57 -13.04 13.66 7.19 -21.68 -12.17 -14.63 4.22 -9.81 -3.79 13.05 -10.86 -12.20 19.99 -3.21
% of Revenue 4.29 5.08 7.93 8.76 7.25 7.15 6.17 6.99 7.41 6.95 6.76 5.84 6.33 6.08 5.70 6.58 5.58 4.68 5.59 5.02
Gross Operating Profit 235 256 204 182 175 213 217 216 218 183 165 165 158 149 153 148 158 167 166 180
Change (%) 9.05 -20.32 -10.83 -4.15 22.29 1.91 -0.52 0.60 -16.04 -9.60 -0.17 -4.29 -5.87 2.93 -2.97 6.29 5.70 -0.45 8.34
% of Revenue 95.71 94.92 92.07 91.24 92.75 92.85 93.83 93.01 92.59 93.05 93.24 94.16 93.67 93.92 94.30 93.42 94.42 95.32 94.41 94.98
SG&A 37 36 35 35 34 40 41 42 48 43 42 43 40 42 43 44 45 47 50 52
Change (%) -1.91 -2.25 0.56 -2.99 15.64 2.16 3.14 15.10 -10.28 -3.16 3.38 -8.45 5.49 2.70 1.47 4.12 4.02 5.77 4.79
% of Revenue 14.97 13.35 15.88 17.75 18.27 17.29 17.52 18.00 20.51 22.02 23.64 24.72 23.53 26.43 26.48 27.43 27.16 26.98 28.39 27.63
R&D 48 54 56 58 61 72 76 84 85 83 85 90 95 99 105 104 105 104 98 100
Change (%) 11.05 4.49 3.98 4.35 18.33 5.99 9.25 1.37 -1.49 2.43 5.05 5.70 4.63 6.18 -1.44 1.00 -1.39 -5.70 2.16
% of Revenue 19.73 19.93 25.34 29.29 32.42 31.40 33.01 35.93 36.04 42.50 48.26 51.28 56.34 62.79 65.03 65.44 62.85 59.19 55.53 52.68
OpEx 107 113 118 120 117 137 138 149 159 154 157 160 161 162 168 168 171 168 168 158
Change (%) 5.70 4.21 1.60 -2.42 17.35 0.67 7.90 6.48 -2.92 1.54 2.39 0.14 0.85 3.53 0.19 1.51 -1.27 -0.19 -6.09
% of Revenue 43.67 41.98 53.25 60.12 62.23 59.78 59.68 64.17 67.61 78.57 88.44 91.60 95.35 102.42 103.43 105.80 102.12 96.30 95.63 83.39
Operating Income 138 157 104 80 71 92 93 83 76 42 20 15 8 -4 -6 -9 -4 6 8 31
Change (%) 13.26 -33.81 -23.26 -10.69 30.09 1.09 -10.82 -8.65 -44.74 -51.31 -28.23 -46.70 -148.84 45.13 65.79 -61.52 -282.56 18.77 309.27
% of Revenue 56.33 58.02 46.75 39.88 37.77 40.22 40.32 35.83 32.39 21.43 11.56 8.40 4.65 -2.42 -3.43 -5.80 -2.12 3.70 4.37 16.61
Interest Expense -6 -3 -3 -2 -3 -7 -3 -3 -2 -3 -5 -6 -2 -2 -2 -2 -2 -3 -4
Change (%) -48.53 -0.00 -44.78 100.89 -50.22 -0.00 -29.56 27.15 80.97 4.19 -57.58 -26.70 25.41 8.78 2.19 33.17 24.30
% of Revenue -2.47 -1.16 -1.41 -0.86 -1.47 -2.92 -1.45 -1.44 -1.21 -1.71 -3.12 -3.38 -1.53 -1.09 -1.40 -1.45 -1.41 -1.87 -2.16
Net Income 147 137 91 67 61 93 91 85 82 49 29 21 14 1 2 -2 1 26 20 42
Change (%) -6.42 -33.80 -26.64 -8.68 52.55 -2.38 -6.70 -3.61 -39.46 -41.66 -27.53 -33.19 -91.84 78.19 -186.92 -135.32 4,100.16 -23.92 111.36
% of Revenue 59.75 50.85 40.98 33.41 32.35 40.40 39.12 36.37 34.69 25.14 16.25 11.92 8.28 0.72 1.25 -1.11 0.37 14.94 11.31 22.20

Source: Capital IQ

Other Listings
GB:0RC6 € 87.72
US:PHMMF
GB:PHME
DE:PMRA € 91.60
ES:PHM € 88.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista